Sort
17,054 grants matching “genome editing”
Improving Preclinical Translation in Alzheimer's Disease Research
$48,965Stacey J Rizzo · University Of Pittsburgh At Pittsburgh · R13 · FY2020 · AG
In vivo regulators of TERT promoter mutant glioblastoma
$48,914Alexandra M Amen · University Of California Berkeley · F32 · FY2020 · CA
ADAD1 and ribosome biogenesis in the post-meiotic male germ cell
$48,898Sarah Potgieter · Rutgers, The State Univ Of N.J. · F31 · FY2025 · HD
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
$48,870Laura Kirkman · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
Recombinational Mechanisms of DNA Repair in Eukaryotes
$48,866Wolf-Dietrich Heyer · University Of California At Davis · R01 · FY2018 · GM
Leveraging CRISPR RNA-guided DNA Transposases for Gene Insertion at the CFTR Locus
$48,666Rebeca Teresa King · Columbia University Health Sciences · F31 · FY2023 · HL
Hemizygous deletion of esential genes enables a novel therqpeutic vulnerability in cancer
$48,576William J Gibson · Harvard Medical School · F30 · FY2016 · CA
From genotype to phenotype: Molecular and functional characterization of the ID3 SNP rs11574 in CVD
$48,464Christopher Andrew Henderson · University Of Virginia · F30 · FY2022 · HL
Administrative Core
$48,258James Even Voss · Scripps Research Institute, The · P01 · FY2025 · HL
Regulation of clathrin-mediated endocytosis by membrane curvature.
$48,240Jessica Marks · University Of California Berkeley · F32 · FY2016 · GM
Genome Editing Treatment for Catecholaminergic Polymorphic Ventricular Tachycardia
$48,225Oliver Moore · Baylor College Of Medicine · F30 · FY2023 · HL
Hemizygous deletion of esential genes enables a novel therqpeutic vulnerability in cancer
$48,120William J Gibson · Harvard Medical School · F30 · FY2015 · CA
Mitotic chromatin and implications in erythroid transcriptional regulation
$48,013Vivek Behera · University Of Pennsylvania · F30 · FY2015 · DK
Cancer Susceptibility and MSI Analyses of Mlh3 Null Mice
$47,980University Of California Irvine · R01 · FY2004 · CA
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
$47,938Alexandra Munch · Icahn School Of Medicine At Mount Sinai · F31 · FY2025 · AG
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
$47,854Mingtao Zhao · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · HL
Role of TREM2 R47H in Alzheimer's disease using novel CRISPR/Cas9 mouse models
$47,799Paul Ja-Wen Cheng-Hathaway · Case Western Reserve University · F30 · FY2018 · AG
Investigating the role of Pdx1 in coordinating translational regulation in pancreatic beta cells
$47,711Austin Lewis Good · University Of Pennsylvania · F30 · FY2016 · DK
Dissecting GWAS Identified Risk Variants in Parkinson's Disease â Functional Role of GPNMB in the Pathogenesis of PD
$47,694Riana Lo Bu · Albert Einstein College Of Medicine · F31 · FY2023 · NS
Understanding the divergent functions of mutant p53
$47,694Margaret Kennedy · Sloan-Kettering Inst Can Research · F31 · FY2023 · CA
Therapeutic Editing of Rod Glycolysis Rescues Retinal Degeneration
$47,694Nicholas David Nolan · Columbia University Health Sciences · F31 · FY2023 · EY
Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC
$47,694Bianca Diaz · Weill Medical Coll Of Cornell Univ · F31 · FY2023 · CA
The role of Zhx2 in CYP2D regulation, oxycodone metabolism, and opioid addiction model behaviors.
$47,694William Lynch · Boston University Medical Campus · F31 · FY2023 · DA
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
$47,694Katherine R. Westover · Emory University · F31 · FY2023 · NS
Determining the cell fate programs of mammalian retina development
$47,694Martin Tran · California Institute Of Technology · F31 · FY2023 · EY